ArticleBMC psychology2025
Efficacy of cognitive and behavioral therapy (CBT) treatment for individuals living with symptoms associated with environmental factors (SAEF): protocol for a randomized controlled trial.
Article in BMC psychology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05973214 (Effectiveness of a Cognitive and Behavioral Treatment Program in People With Idiopathic Environmental Intolerance), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Effectiveness of a Cognitive and Behavioral Treatment Program in People With Idiopathic Environmental Intolerance (IEI)
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundTreatment for symptoms associated with environmental factors (SAEF), such as electrohypersensitivity or multiple chemical sensitivity, have been sparsely investigated thus far.
methodsIn this parallel, two-armed open-label randomized controlled trial, we will apply a treatment model for SAEF based on cognitive behavioral therapy. Our goal is to recruit N = 68 people with either multiple chemical sensitivity or electrohypersensitivity, or both, by informing our professional network of healthcare practitioners and patient groups. Prospective participants will be randomized into a treatment or a waitlist-control group. The primary outcome is physical health-related quality of life, while attendance, measures of symptom experience, cognitive and emotional processing, and comorbid psychopathology will be assessed as secondary outcomes. Delivered in-person and/or online through videoconferencing tools, the treatment will consist of 12 individual CBT-inspired sessions, guided by specialized psychologists and spanning eight weeks. Patients will be assessed at three timepoints, each 3 months apart, meaning we will have pre- and post-treatment measurements for both groups. DISCUSSION: This randomized controlled trial will be the first to thoroughly test a cognitive behavioral therapy intervention for individuals living with SAEF. We intend to meet critical unmet needs for specialized healthcare in this population. Additionally, by adding many secondary outcomes that have not, or not sufficiently, been studied in individuals with SAEF, we will gain a more comprehensive understanding of these patients’ thoughts, feelings, and behaviors.
trial registrationThis trial was first prospectively registered at ClinicalTrials.gov, code NCT05973214, on the 26th July 2023.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.